MDxHealth SA raised earnings guidance for the year 2024. Based on our visibility to sustainable growth, company is taking revenue guidance up from $83-85 million to $85-87 million, representing 23% year-over-year revenue growth at the midpoint of guidance.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | +3.82% |
|
-0.35% | -27.16% |
08/07 | Mdxhealth SA Raises Earnings Guidance for the Year 2024 | CI |
08/07 | MDxHealth SA Announces Board Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.16% | 75.44M | |
+24.77% | 46.56B | |
+45.38% | 41.67B | |
+0.17% | 41.16B | |
+33.18% | 32.4B | |
+21.03% | 28.18B | |
-6.35% | 28.1B | |
+49.05% | 14.52B | |
+47.23% | 13.74B | |
+3.21% | 12.17B |
- Stock Market
- Equities
- MDXH Stock
- News MDxHealth SA
- Mdxhealth SA Raises Earnings Guidance for the Year 2024